ArticleClinical pharmacokinetics2021

Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor.

Angela Joubert James et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.